Bruker Corporation

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-13 pm EDT			5-day change	1st Jan Change
65.66 ^USD	+1.44%		+2.58%	-10.64%

Sep. 06	Transcript : Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM
Sep. 04	Transcript : Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM

NovAliX SAS announced that it has received funding from Bruker Corporation

August 06, 2024

NovAliX SAS announced that it has raised funding on August 7, 2024. The transaction included participation from new investor, Bruker Corporation. The company issued common shares in the transaction.

Latest news about Bruker Corporation

Transcript : Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM	Sep. 06
Transcript : Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM	Sep. 04
Bruker Announces Successful Installation of 1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute	Aug. 13	CI
Bruker Keeps Quarterly Dividend at $0.05 a Share, Payable Sept. 16 to Stockholders of Record Sept. 2	Aug. 12	MT
Bruker Corporation Announces Quarterly Cash Dividend, Payable on September 16, 2024	Aug. 12	CI
Bruker Acquires Minority Stake in NovAliX	Aug. 07	MT
Philip Ma Resigns from Board of Bruker Corporation	Aug. 07	CI
Bruker Corporation and NovAliX Collaborate Strategically to Develop Novel Drug Discovery Technologies and Methods	Aug. 07	CI
NovAliX SAS announced that it has received funding from Bruker Corporation	Aug. 06	CI
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday	Aug. 06	MT
Transcript : Bruker Corporation, Q2 2024 Earnings Call, Aug 06, 2024	Aug. 06
Bruker Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised	Aug. 06	MT
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q2 Revenue $800.7M, vs. Street Est of $797.8M	Aug. 06	MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q2 EPS $0.52, vs. Street Est of $0.51	Aug. 06	MT
Bruker Corporation Updates Financial Guidance for the Full Year of 2024	Aug. 06	CI
Bruker Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Aug. 06	CI
Certain Common Stock of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024.	Jul. 28	CI
Certain Stock Options of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024.	Jul. 28	CI
Certain Restricted Stock Units of Bruker Corporation are subject to a Lock-Up Agreement Ending on 29-JUL-2024.	Jul. 28	CI
Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	Jul. 09	MT
Bruker Corporation Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie in Berlin	Jul. 02	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Small Cap Comp Value Index	Jun. 30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Midcap Value Index	Jun. 30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 3000E Value Index	Jun. 30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 2500 Value Index	Jun. 30	CI

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.

Employees

9,707

Sector

Advanced Medical Equipment & Technology

Calendar

2024-10-30 - Q3 2024 Earnings Release (Projected)

More about the company